These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37127087)

  • 1. Neuronal activity and NIBS in developmental myelination and remyelination - Current state of knowledge.
    Scheinok TJ; D'Haeseleer M; Nagels G; De Bundel D; Van Schependom J
    Prog Neurobiol; 2023 Jul; 226():102459. PubMed ID: 37127087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
    Marro BS; Skinner DD; Cheng Y; Grist JJ; Dickey LL; Eckman E; Stone C; Liu L; Ransohoff RM; Lane TE
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.
    Zhang S; Zhu X; Gui X; Croteau C; Song L; Xu J; Wang A; Bannerman P; Guo F
    J Neurosci; 2018 Feb; 38(7):1802-1820. PubMed ID: 29335358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in oligodendrocyte development and remyelination.
    Ngo C; Kothary R
    J Neurochem; 2022 Aug; 162(4):310-321. PubMed ID: 35536759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?
    Chen CZ; Neumann B; Förster S; Franklin RJM
    Open Biol; 2021 Jan; 11(1):200352. PubMed ID: 33497588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seeing is believing: Identifying remyelination in the central nervous system.
    Hill MFE; Cunniffe NG; Franklin RJM
    Curr Opin Pharmacol; 2022 Oct; 66():102269. PubMed ID: 35926475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T; Yoshida S
    Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
    Mi S; Miller RH; Tang W; Lee X; Hu B; Wu W; Zhang Y; Shields CB; Zhang Y; Miklasz S; Shea D; Mason J; Franklin RJ; Ji B; Shao Z; Chédotal A; Bernard F; Roulois A; Xu J; Jung V; Pepinsky B
    Ann Neurol; 2009 Mar; 65(3):304-15. PubMed ID: 19334062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal Signal-Regulated Oligodendrocyte Myelination and Remyelination.
    Miyata S
    Adv Exp Med Biol; 2019; 1190():33-42. PubMed ID: 31760636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa opioid receptor and oligodendrocyte remyelination.
    Wang F; Mei F
    Vitam Horm; 2019; 111():281-297. PubMed ID: 31421704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
    Gaesser JM; Fyffe-Maricich SL
    Exp Neurol; 2016 Sep; 283(Pt B):501-11. PubMed ID: 26957369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
    Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
    Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelination: the true regeneration of the central nervous system.
    Crawford AH; Chambers C; Franklin RJ
    J Comp Pathol; 2013; 149(2-3):242-54. PubMed ID: 23831056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
    Unal DB; Caliari SR; Lampe KJ
    Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of oligodendroglial Stat3 is required for efficient remyelination.
    Steelman AJ; Zhou Y; Koito H; Kim S; Payne HR; Lu QR; Li J
    Neurobiol Dis; 2016 Jul; 91():336-46. PubMed ID: 27060559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair.
    Breton JM; Long KLP; Barraza MK; Perloff OS; Kaufer D
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target.
    Nakahara J; Aiso S; Suzuki N
    Expert Opin Ther Targets; 2009 Dec; 13(12):1375-86. PubMed ID: 19839715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.